PPD (Pharmaceutical Product Development)
↗Wilmington, North Carolina, USA
PPD, part of Thermo Fisher Scientific, is a leading global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory, and lifecycle management services. The company specializes in accelerating the development of life-changing therapies by providing Phase I-IV clinical trial management, bioanalytical laboratory services, and peri- and post-approval studies.
Following its $17.4 billion acquisition by Thermo Fisher Scientific in 2021, PPD operates as the core of Thermo Fisher's Clinical Research Group. It leverages a massive global network of clinical sites and advanced data analytics to support pharmaceutical, biotechnology, medical device, and government organizations in bringing new medicines to market efficiently.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Contract Research Organization (CRO)
SIZE & FINANCIALS
Employees:10000+
Revenue:$5B-$10B
Founded:1985
Ownership:subsidiary
Status:acquired
FUNDING
Stage:Acquired
Investors:Carlyle Group (Former), Hellman & Friedman (Former)
STOCK
Exchange:NYSE
Ticker:TMO
Market Cap:$200B+
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 4 (Post-Market)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Vaccines
Active Trials:2100
Trial Phases:Phase 1: 450 | Phase 2: 600 | Phase 3: 800 | Phase 4: 250
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Thermo Fisher Scientific
Acquired By:Thermo Fisher Scientific (2021-12-01)
Subsidiaries:Evidera, Accelerated Enrollment Solutions (AES), CorEvitas
Key Partnerships:AstraZeneca (R&D partnership in Sweden), BARDA (Phase II platform trial for ARDS), Medidata (Clinical trial technology collaboration), Datavant (Real-world data interoperability)
COMPETITION
Position:Leader
Competitors:IQVIA, ICON plc, Labcorp (Fortrea), Syneos Health, Parexel
LEADERSHIP
Key Executives:
David Johnston - SVP and President, Clinical Research
Sebastian Pacios - SVP, Clinical Research
Scientific Founders:Fred Eshelman
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PPD (Pharmaceutical Product Development). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.